Otogenetics

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

Discovery of a novel ligand that modulates the protein–protein interactions of the AAA+ superfamily oncoprotein reptin

August 6, 2024

Healy AR, Houston DR, Remnant L, Huart AS, Brychtova V, Maslon MM, Meers O, Muller P, Krejci A, Blackburn EA, Vojtesek B, Hernychova L, Walkinshaw MD, Westwood NJ, Hupp T. (2015) Discovery of a novel ligand that modulates the protein–protein interactions of the AAA+ superfamily oncoprotein reptin. Chem. Sci6, 3109-3116

Otogenetics
  • 4553 Winters Chapel Rd., Suite 100 Atlanta, GA 30360
  • +1 (855)-686-4363
Contact Us

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

  • Privacy Policy

© Otogenetics 2025 All Rights Reserved.